sales@businessmarketinsights.com +1 646 791 7070 | +91-020 69018608

Cancer Chemotherapy Market Size & Forecast

Download Free Sample View Report Summary
Historic: 2021-2023 Base Year: 2024 Forecast: 2025–2031
US$ 39.50 Billion
Market Size 2024 · Base Year
US$ 84.04 Billion
Projected Market Size by 2031
11.39%
CAGR · 2025–2031
Download Free Sample View Report Summary
sales@businessmarketinsights.com +1 646 791 7070 | +91-020 69018608
SHARE
BMIPUB00031705 56+ Countries Covered 10 Major Companies Profiled PEST & SWOT Analysis Competitive Heat Map
At a Glance

Report Coverage

56 +
Countries
56+ countries across North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa
11
Year Assessment
Comprehensive Market Analysis Covering 3 Years of Historical Data (2021–2023), Base Year (2024), and 7-Year Forecast (2025–2031)
10 +
Major Players
Major companies profiled including Astellas Pharma Inc, Eli Lilly and Co, Novartis AG, Merck KGaA, Johnson & Johnson
200
Report Pages
Pages of deep-dive analysis with PEST, SWOT, competitive heat maps and datasets
What's Fueling Growth

Market Drivers

  • The rising global incidence of cancer, coupled with an aging population

  • Increasing access to oncology care in emerging markets

  • Combination with surgery, radiation, and targeted therapies

Where Growth Opportunities Exist

Key Opportunities

  • Artificial intelligence in developing personalized chemotherapy regimens and optimizing dosing to minimize toxicity and maximize efficacy

What Could Slow It Down

Market Restraints

  • Severe side effect

  • High treatment cos

  • Drug resistance issues

Market Segmentation

Coverage by Segment

Therapy Type

Alkylating Agents
Antimetabolites
Anti-Tumor Antibiotics

Indication

Blood Cancer
Lung Cancer
Breast Cancer

End User

Hospital Pharmacies
Retail Pharmacies
Online Stores
Geographic Breakdown

Regional Intelligence

NA North America
EU Europe
APAC Asia-Pacific
SCA South & Central America
MEA Middle East & Africa
Competitive Landscape

Major Market Players

Listed for reference — companies are not ranked in any particular order.

Astellas Pharma Inc
Eli Lilly and Co
Novartis AG
Merck KGaA
Johnson & Johnson
AstraZeneca
Pfizer Inc
Bristol Myers Squibb
F. Hoffmann-La Roche Ltd
AbbVie
What's Inside

Report Scope & Deliverables

Market Size 2024 US$ 39.50 Billion
Market Size 2031 US$ 84.04 Billion
CAGR 2025–2031 11.39%
Segments By Therapy Type (Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics)  |  By Indication (Blood Cancer, Lung Cancer, Breast Cancer)  |  By End User (Hospital Pharmacies, Retail Pharmacies, Online Stores)
Geographies North America (US, Canada, Mexico)  ·  Europe (Germany, Italy, France, U.K., Spain, Belgium, Netherlands, Luxembourg, Norway, Finland, Denmark, Sweden, Switzerland, Austria, Greece, Portugal, Russia, Poland, Romania, Czech Republic, Ukraine, Slovakia, Bulgaria)  ·  Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Taiwan, Bangladesh)  ·  South and Central America (Brazil, Argentina, Chile, Colombia, Peru)  ·  Middle East and Africa (Saudi Arabia, United Arab Emirates, Kuwait, Bahrain, Qatar, Oman, Turkiye, South Africa, Egypt, Nigeria, Algeria)
Deliverables Historical analysis with CAGR · PEST & SWOT analysis · Market Size at Global, Regional, and Country Levels · Competitive heat map · Company profiles · Excel dataset
Report Code BMIPUB00031705
Lead Analyst Krishna Sunthwal — Analyst, Research · View Profile
With Full Report Access

Gain actionable insights with 200 pages of in-depth Cancer Chemotherapy Market, including historical trends, 7-year market forecasts, SWOT analysis, competitive landscapes, and downloadable Excel datasets in a single comprehensive package.

View Report Summary Download Free Sample